Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
Japan · Delayed Price · Currency is JPY 2,366.50
-20.50 (-0.86%)
May 8, 2026, 3:30 PM JST
Rohto Pharmaceutical Market Cap
Rohto Pharmaceutical has a market cap or net worth of 534.74 billion as of May 8, 2026. Its market cap has increased by 4.41% in one year.
Market Cap
534.74B
Enterprise Value
529.84B
Revenue
335.80B
Ranking
n/a
PE Ratio
15.92
Stock Price
2,366.50
Market Cap Chart
Since July 4, 1997, Rohto Pharmaceutical's market cap has increased from 64.95B to 534.74B, an increase of 723.36%. That is a compound annual growth rate of 7.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 534.74B | -9.95% |
| Dec 30, 2025 | 593.83B | -9.54% |
| Dec 30, 2024 | 656.47B | 1.21% |
| Dec 29, 2023 | 648.60B | 22.54% |
| Dec 30, 2022 | 529.28B | 33.52% |
| Dec 30, 2021 | 396.39B | 13.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unicharm | 1.58T |
| Shiseido Company | 1.26T |
| Kobayashi Pharmaceutical | 431.69B |
| Lion Corporation | 420.65B |
| KOSE Holdings | 315.69B |
| Pola Orbis Holdings | 285.01B |
| Paltac | 282.39B |
| MTG Co., Ltd. | 239.91B |